AT9283

AT9283 · Astex Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AT9283, covering 2014-12-02 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias [Phase 1, Phase 2]